oxytetracycline

oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with oxytetracycline?

oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with oxytetracycline

MeSH term MeSH ID Detail
Bacteremia D016470 9 associated lipids
Helicobacter Infections D016481 21 associated lipids
Ehrlichiosis D016873 2 associated lipids
Encephalitozoonosis D016890 2 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Primate Diseases D018419 2 associated lipids
Parasitemia D018512 5 associated lipids
Vaginal Discharge D019522 2 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Per page 10 20 50 100 | Total 137

PubChem Associated disorders and diseases

What pathways are associated with oxytetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with oxytetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with oxytetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with oxytetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with oxytetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with oxytetracycline?

Disease model

Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with oxytetracycline

Download all related citations
Per page 10 20 50 100 | Total 5138
Authors Title Published Journal PubMed Link
Magonigle RA and Newby TJ Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections. 1984 Am. J. Vet. Res. pmid:6731981
Nicoletti P et al. Efficacy of various treatment regimens, using liposomal streptomycin in cows with brucellosis. 1989 Am. J. Vet. Res. pmid:2505648
Magonigle RA et al. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis. 1978 Am. J. Vet. Res. pmid:697150
Marín CM et al. Efficacy of long-acting oxytetracycline alone or in combination with streptomycin for treatment of Brucella ovis infection of rams. 1989 Am. J. Vet. Res. pmid:2712423
Wooley RE et al. Attempted reversal of oxytetracycline resistance of Proteus mirabilis by EDTA-tromethamine lavage in experimentally induced canine and feline cystitis. 1975 Am. J. Vet. Res. pmid:811139
Bretzlaff KN et al. Distribution of oxytetracycline in the healthy and diseased postpartum genital tract of cows. 1983 Am. J. Vet. Res. pmid:6869979
Bretzlaff KN et al. Distribution of oxytetracycline in genital tract tissues of postpartum cows given the drug by intravenous and intrauterine routes. 1983 Am. J. Vet. Res. pmid:6869980
Kuttler KL Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle. 1983 Am. J. Vet. Res. pmid:6869997
Bowen JM and McMullan WC Influence of induced hypermagnesemia and hypocalcemia on neuromuscular blocking property of oxytetracycline in the horse. 1975 Am. J. Vet. Res. pmid:1147343
YODER HW and PACKER RA Bovine blood serum concentrations of terramycin (Oxytetracycline) following intravenous and intramuscular administration. 1954 Am. J. Vet. Res. pmid:13171501
Kaneene JB et al. Drug residues in milk after intrauterine injection of oxytetracycline, lincomycin-spectinomycin, and povidone-iodine in cows with metritis. 1986 Am. J. Vet. Res. pmid:2942064
MacNeil JD et al. Bioassay techniques and high-performance liquid chromatography for detection of oxytetracycline residues in tissues from calves. 1989 Am. J. Vet. Res. pmid:2919831
Lubbers BV et al. Effects of two simulated oxytetracycline dosing regimens on horizontal transfer of antimicrobial resistance plasmids in an in vitro pharmacodynamic model. 2011 Am. J. Vet. Res. pmid:21728847
Palmer JE et al. Effect of treatment with oxytetracycline during the acute stages of experimentally induced equine ehrlichial colitis in ponies. 1992 Am. J. Vet. Res. pmid:1476312
Oukessou M et al. Pharmacokinetics and local tolerance of a long-acting oxytetracycline formulation in camels. 1992 Am. J. Vet. Res. pmid:1416372
byford RL et al. Chemoprophylaxis of vector-borne anaplasmosis with sustained-release boluses. 1981 Am. J. Vet. Res. pmid:7340579
Larson VL and Stowe CM Plasma and tissue concentrations of oxytetracycline in the horse after intravenous administration. 1981 Am. J. Vet. Res. pmid:7340586
Wintz LR et al. Age-dependent effects of systemic administration of oxytetracycline on the viscoelastic properties of rat tail tendons as a mechanistic basis for pharmacological treatment of flexural limb deformities in foals. 2012 Am. J. Vet. Res. pmid:23176422
Button C and Mülders MS Effects of oxytetracycline in propylene glycol, oxytetracycline in saline solution, and propylene glycol alone on blood ionized calcium and plasma total calcium in sheep. 1984 Am. J. Vet. Res. pmid:6476580
Paulsen DB et al. Use of an indwelling bronchial catheter model of bovine pneumonic pasteurellosis for evaluation of therapeutic efficacy of various compounds. 1992 Am. J. Vet. Res. pmid:1524292